Main Article

This year is expected to continue the growth seen in recent years, with a 6% to 7% increase in total lab industry revenues that will push the lab market to $55 billion overall. This growth is largely attributed to aging demographics, continued growth from high quality pathology and lab medicine hospital outreach labs, regional labs, and the large commercial labs. But this year, labs will also face many of the same issues they have grappled with in recent years, including downward pricing pressure from managed care organizations and the CMS competitive bidding demonstration project. To get a sense of where the industry is and where it’s heading, Laboratory Industry Report talked to laboratory executives, industry leaders, and analysts for their thoughts and predictions for 2008 and beyond. LIR found that while they have significant concerns, they are also optimistic about future growth possibilities.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

January 2008 - Table of Contents

LIR January 2008 (full PDF issue)

Competitive Demo Bids Due Feb. 15: CMS Confirms List of Excluded Cities

Quest, LabCorp, Sonic Land Humana Contract Extensions

‘First to File’ Patent Reform Efforts Underscore Labs’ Need to Protect IP

Goldman Sachs Identifies Current Challenges, Future Growth for Quest and LabCorp

Outlook for the Lab Industry: Five Execs’ Predictions for 2008

India’s Lal PathLabs Intent on Outsourcing United States Testing

Lab Stocks up 17% in ’07, Two New Companies Added for 2008

Caris Diagnostics to Acquire Molecular Profiling Institute